Curciarello Renata, Docena Guillermo H, MacDonald Thomas T
Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Instituto de Estudios Inmunológicos y Fisiopatológicos -IIFP-CONICET-Universidad Nacional de La Plata, La Plata, Argentina.
Front Med (Lausanne). 2017 Aug 7;4:126. doi: 10.3389/fmed.2017.00126. eCollection 2017.
Crohn's disease is an idiopathic disorder of the gut thought to be caused by a combination of environmental and genetic factors in susceptible individuals. It is characterized by chronic transmural inflammation of the terminal ileum and colon, with typical transmural lesions. Complications, including fibrosis, mean that between 40 and 70% of patients require surgery in the first 10 years after diagnosis. Presently, there is no evidence that the current therapies which dampen inflammation modulate or reverse intestinal fibrosis. In this review, we focus on cytokines that may lead to fibrosis and stenosis and the contribution of experimental models for understanding and treatment of gut fibrosis.
克罗恩病是一种肠道特发性疾病,被认为是由环境因素和遗传因素共同作用于易感个体所致。其特征为回肠末端和结肠的慢性透壁性炎症,并伴有典型的透壁性病变。包括纤维化在内的并发症意味着40%至70%的患者在确诊后的头10年内需要接受手术。目前,尚无证据表明当前抑制炎症的疗法能调节或逆转肠道纤维化。在本综述中,我们聚焦于可能导致纤维化和狭窄的细胞因子,以及实验模型在理解和治疗肠道纤维化方面的作用。